Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sailish Honap

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
The New Zealand Medical Journal|April 13, 2023
Amoebic colitis masquerading as inflammatory bowel disease for a decadeSailish Honap, Simon Anderson
Clinical Liver Disease|March 8, 2021
Fat and Hidden Liver CancerSailish Honap, Jude A Oben
Journal of Crohn'S & Colitis|February 8, 2025
Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel diseaseSailish Honap, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|August 21, 2023
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?Sailish Honap, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|July 9, 2025
Editorial: JAK to JAK-Navigating Intraclass JAK Inhibitor Switching in Inflammatory Bowel DiseaseJennie Clough, Kamal Patel, Sailish Honap
Journal of Crohn'S & Colitis|April 26, 2026
Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entityMichael Colwill, Ashley Spencer, Sailish Honap
Alimentary Pharmacology & Therapeutics|July 8, 2021
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?Sailish Honap, Polychronis Pavlidis, Peter M Irving
Gastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2025
ReplySailish Honap, Kamal Patel, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|June 11, 2024
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized TrialsSailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
The New Zealand Medical Journal|April 13, 2023
Amoebic colitis masquerading as inflammatory bowel disease for a decadeSailish Honap, Simon Anderson
Clinical Liver Disease|March 8, 2021
Fat and Hidden Liver CancerSailish Honap, Jude A Oben
Journal of Crohn'S & Colitis|February 8, 2025
Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel diseaseSailish Honap, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|August 21, 2023
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?Sailish Honap, Laurent Peyrin-Biroulet
Alimentary Pharmacology & Therapeutics|July 9, 2025
Editorial: JAK to JAK-Navigating Intraclass JAK Inhibitor Switching in Inflammatory Bowel DiseaseJennie Clough, Kamal Patel, Sailish Honap
Journal of Crohn'S & Colitis|April 26, 2026
Anogenital cutaneous Crohn's disease: effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entityMichael Colwill, Ashley Spencer, Sailish Honap
Alimentary Pharmacology & Therapeutics|July 8, 2021
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?Sailish Honap, Polychronis Pavlidis, Peter M Irving
Gastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2025
ReplySailish Honap, Kamal Patel, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|June 11, 2024
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized TrialsSailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Pageof 8